Back
Innate Pharma SA Stock Price Chart
Sponsored
IPHA
Sponsored
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
13
IPHA
Innate Pharma SA
Last Price:
1.90
Seasonality Move:
18.08%
7 Day Trial
ALL ACCESS PASS
$
7
Beginner's Guide To Growing A Small Investment
Click here to download your free copy now!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Innate Pharma SA Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.85 | Sell |
20-day SMA: | 2 | Sell |
50-day SMA: | 2.15 | Sell |
200-day SMA: | 2.38 | Sell |
8-day EMA: | 1.86 | Sell |
20-day EMA: | 1.97 | Sell |
50-day EMA: | 2.09 | Sell |
200-day EMA: | 2.34 | Sell |
Innate Pharma SA Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 39.58 | Sell |
Chaikin Money Flow: | 5432 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.88 - 2.18) | Sell |
Bollinger Bands (100): | (2 - 2.34) | Sell |
Innate Pharma SA Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Innate Pharma SA Stock
Is Innate Pharma SA Stock a Buy?
- Innate Pharma SA share price is 1.83 while IPHA 8-day simple moving average is 1.85, which is a Sell signal.
- The stock price of IPHA is 1.83 while Innate Pharma SA 20-day SMA is 2.00, which makes it a Sell.
- Innate Pharma SA 50-day simple moving average is 2.15 while IPHA share price is 1.83, making it a Sell technically.
- IPHA stock price is 1.83 and Innate Pharma SA 200-day simple moving average is 2.38, creating a Sell signal.
IPHA Technical Analysis vs Fundamental Analysis
Sell
13
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy or a Sell?
-
Innate Pharma SA stock is rated a Sell
The current Innate Pharma SA [IPHA] share price is $1.83. The Score for IPHA is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Innate Pharma SA Stock Info
Market Cap:
148.14M
Price in USD:
1.83
Share Volume:
8.04K
Innate Pharma SA 52-Week Range
52-Week High:
3.15
52-Week Low:
1.70
Sell
13
Innate Pharma SA (IPHA)
is a Sell
Innate Pharma SA Share Price Forecast
-
What is the Innate Pharma SA stock price today?
The Innate Pharma SA stock price is 1.83 USD today. -
Will IPHA stock go up or go down?
Innate Pharma SA> share price is forecast to RISE/FALL based on technical indicators -
Is Innate Pharma SA overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Innate Pharma SA is overvalued.
Is Innate Pharma SA Stock a Buy?
- Innate Pharma SA share price is 1.83 while IPHA 8-day exponential moving average is 1.86, which is a Sell signal.
- The stock price of IPHA is 1.83 while Innate Pharma SA 20-day EMA is 1.97, which makes it a Sell.
- Innate Pharma SA 50-day exponential moving average is 2.09 while IPHA share price is 1.83, making it a Sell technically.
- IPHA stock price is 1.83 and Innate Pharma SA 200-day simple moving average is 2.34, creating a Sell signal.
Fundamental Analysis of Innate Pharma SA
Is Innate Pharma SA a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Innate Pharma SA
Should I short Innate Pharma SA stock?
- IPHA Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Innate Pharma SA is a Sell
- Innate Pharma SA Relative Strength Index (RSI) is 39.58, which suggest Innate Pharma SA is oversold
- The Bollinger Bands (25) for Innate Pharma SA is (1.88 - 2.18), which suggest Innate Pharma SA is a Sell
- The Bollinger Bands (100) for Innate Pharma SA is (2 - 2.34), which suggest Innate Pharma SA is a Sell
* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.